My watch list
my.bionity.com  
Login  

Migraine drug race turns its final corner, FDA decisions in sight

Nature Biotechnology 36, 207 (2018). doi:10.1038/nbt0318-207

Author: Elie Dolgin

Authors:   Elie Dolgin
Journal:   Nature Biotechnology
Volume:   36
edition:   3
Year:   2018
Pages:   207
DOI:   10.1038/nbt0318-207
Publication date:   06-Mar-2018
Facts, background information, dossiers
More about Nature Publishing Group
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE